Immunic, Inc. ( IMUX) - Key Metrics
IMUX Revenue per Share metrics
| Date | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share | |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | ? | ? | ? | ? |
IMUX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
IMUX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -5.17% | ? |
| 2025Q4 | -23.20% | ? |
| 2025Q3 | -11.82% | ? |
| 2025Q2 | -26.71% | ? |
| 2025Q1 | -19.76% | ? |
IMUX
Price: $13.71
52 week price:
Earnings Per Share: -4.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562646
Market Capitalization: 127.4 million